#ellipta

[zeroviraluniverse-blog]

BRIEF-GlaxoSmithkline Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma

Visit Now - http://zeroviral.com/brief-glaxosmithkline-announces-chmp-positive-opinion-for-labelling-update-to-relvar-ellipta-in-patients-with-asthma/

BRIEF-GlaxoSmithkline Announces CHMP Positive Opinion for Labelling Update to Relvar Ellipta in Patients with Asthma

Jan 26 (Reuters) – GlaxoSmithkline Plc:

* GSK‘S RELVAR ELLIPTA – POSITIVE CHMP OPINION

* GSK ANNOUNCES CHMP POSITIVE OPINION FOR LABELLING UPDATE TO RELVAR ELLIPTA IN PATIENTS WITH ASTHMA

* ‍NO NEW SAFETY SIGNALS WERE IDENTIFIED AND ADVERSE EVENT DATA WERE CONSISTENT WITH KNOWN SAFETY PROFILE FOR FF/VI ESTABLISHED IN PATIENTS WITH ASTHMA​

* ‍FINAL DECISION IS ANTICIPATED TOWARDS END OF Q1 OF 2018 ​ Source textual content for Eikon: Further firm protection: ([email protected])

Our Standards:The Thomson Reuters Trust Principles.

[christopherporreca01]

BRIEF-GlaxoSmithKline says European Commission grants marketing authorisation for Trelegy Ellipta Nov 16 (Reuters) - Glaxosmithkline Plc * TRELEGY ELLIPTA ONCE-DAILY SINGLE INHALER TRIPLE THERAPY GAINS MARKETING AUTHORISATION IN EUROPE FOR TREATMENT OF COPD​ Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles. Source link

[amcrasto]

Theravance Announces FDA Advisory Committee to Review ANORO(TM) ELLIPTA(TM) (UMEC/VI) for COPD

    Theravance Announces FDA Advisory Committee to Review ANORO(TM) ELLIPTA(TM) (UMEC/VI) for COPD

  [youtube=http://www.youtube.com/watch?v=2nBPqSiLg5E&w=560&h=315]

SOUTH SAN FRANCISCO, CA — 08/01/13 –Theravance, Inc.  today announced that on September…

View Post